Multicenter retrospective study shows high obliteration rates in patients with hereditary hemorrhagic telangiectasia, suggesting a safe treatment option.
No takes yet. Share an insight, caveat, or question.
Akiyama et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: